Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

GORDON S WARNER

Allopathic & Osteopathic Physicians Internal Medicine Sleep Medicine

NPI
1194754788
CMS profile
190513
Location
CULLMAN, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$46,248.74

237 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

By paying entity

PY2019 · entire year · sorted by reported total

Page 3 of 5; records 101–150 of 237 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

GORDON S WARNER

NPI 1194754788 · CMS profile ID 190513

Allopathic & Osteopathic Physicians / Internal Medicine / Sleep Medicine

CULLMAN, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 5; records 101–150 of 237 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1194754788?year=2019&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
GORDON S WARNER, NPI 1194754788, CMS profile ID 190513. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 237 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1194754788?year=2019&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). GORDON S WARNER, NPI 1194754788, CMS profile ID 190513. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 237 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1194754788?year=2019&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
GORDON S WARNER, NPI 1194754788, CMS profile ID 190513, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 5; records 101–150 of 237 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1194754788?year=2019&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

237 matching records · $46,248.74 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 237 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 237.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Genentech USA, Inc. $19.7208/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681380981 CMS
ARBOR PHARMACEUTICALS, INC. $16.6207/31/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697361423 CMS
GlaxoSmithKline, LLC. $13.6807/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670989033 CMS
Sunovion Pharmaceuticals Inc. $13.3507/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688158393 CMS
Mylan Specialty L.P. $1,032.0007/25/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694758503 CMS
Mylan Specialty L.P. $181.6307/25/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694758505 CMS
Mylan Specialty L.P. $1,032.0007/25/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694758521 CMS
Mylan Specialty L.P. $130.5007/25/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694758599 CMS
Mylan Specialty L.P. $46.5107/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694759695 CMS
Mylan Specialty L.P. $447.2007/25/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694759697 CMS
Mylan Specialty L.P. $46.5107/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694759703 CMS
Mylan Specialty L.P. $19.0007/25/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694761489 CMS
Mylan Specialty L.P. $125.8607/25/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694811255 CMS
Mylan Specialty L.P. $552.8007/25/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694812101 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $11.9807/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700401921 CMS
Ironshore Pharmaceuticals Inc. $13.8007/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 707568149 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.6307/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700401923 CMS
JAZZ PHARMACEUTICALS INC. $3.7307/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684167431 CMS
JAZZ PHARMACEUTICALS INC. $6.1707/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684167429 CMS
AstraZeneca Pharmaceuticals LP $12.3207/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685255387 CMS
Merck Sharp & Dohme Corporation $13.0307/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695651113 CMS
Genentech USA, Inc. $14.9507/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681413485 CMS
Philips Electronics North America Corporation $29.1007/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684073131 CMS
GlaxoSmithKline, LLC. $63.8007/12/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671514161 CMS
Grifols USA, LLC $12.7007/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 692590535 CMS
AstraZeneca Pharmaceuticals LP $13.6807/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685268023 CMS
JAZZ PHARMACEUTICALS INC. $14.1707/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684167427 CMS
GlaxoSmithKline, LLC. $3,600.0007/08/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670464469 CMS
GlaxoSmithKline, LLC. $14.3207/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670464537 CMS
Mylan Specialty L.P. $53.3006/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694758403 CMS
GlaxoSmithKline, LLC. $13.3306/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671447281 CMS
GlaxoSmithKline, LLC. $11.7806/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671453231 CMS
Insmed, Inc. $18.1606/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 693321419 CMS
Insmed, Inc. $99.9906/19/2019 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 693327845 CMS
Sunovion Pharmaceuticals Inc. $16.8006/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688158391 CMS
Philips Electronics North America Corporation $26.8406/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684073125 CMS
Mylan Specialty L.P. $6.8906/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694758507 CMS
Mylan Specialty L.P. $11.8306/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694811367 CMS
AstraZeneca Pharmaceuticals LP $17.8706/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685213825 CMS
Genentech USA, Inc. $15.7806/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681192301 CMS
GlaxoSmithKline, LLC. $12.3706/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671511025 CMS
AstraZeneca Pharmaceuticals LP $15.0206/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685520253 CMS
Grifols USA, LLC $14.2506/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 692609243 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $13.6506/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700401925 CMS
Merck Sharp & Dohme Corporation $19.0405/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695522897 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.7505/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700401927 CMS
GlaxoSmithKline, LLC. $11.6605/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671440273 CMS
AstraZeneca Pharmaceuticals LP $13.2005/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685025630 CMS
GlaxoSmithKline, LLC. $14.5705/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670587283 CMS
Mylan Specialty L.P. $6.1505/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694762107 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $46,248.74 237
PY2020 $26,407.29 151
PY2021 $4,867.99 136
PY2022 $11,202.62 169
PY2023 $3,281.51 149
PY2024 $3,165.58 143
PY2025 $5,152.61 166

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $115,935.25 26
PY2024 Principal investigator $192,123.81 6
PY2023 Principal investigator $325,614.12 19
PY2022 Principal investigator $38,401.50 22
PY2021 Principal investigator $11,500.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

26 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Alkermes, Inc. $1,000.00 12/10/2025 Non-covered Recipient Entity
CULLMAN CLINICAL TRIALS, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208615029
Principal investigator 1 Alkermes, Inc. $2,032.00 12/10/2025 Non-covered Recipient Entity
CULLMAN CLINICAL TRIALS, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208615587
Principal investigator 1 Alkermes, Inc. $2,500.00 12/10/2025 Non-covered Recipient Entity
CULLMAN CLINICAL TRIALS, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208622491
Principal investigator 1 Alkermes, Inc. $10,000.00 12/10/2025 Non-covered Recipient Entity
CULLMAN CLINICAL TRIALS, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208624312
Principal investigator 1 Alkermes, Inc. $51.75 10/02/2025 Non-covered Recipient Entity
CULLMAN CLINICAL TRIALS, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208616905
Principal investigator 1 Alkermes, Inc. $71.60 10/02/2025 Non-covered Recipient Entity
CULLMAN CLINICAL TRIALS, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208617525
Principal investigator 1 Alkermes, Inc. $71.60 10/02/2025 Non-covered Recipient Entity
CULLMAN CLINICAL TRIALS, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208621616
Principal investigator 1 Alkermes, Inc. $79.50 10/02/2025 Non-covered Recipient Entity
CULLMAN CLINICAL TRIALS, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208622057
Principal investigator 1 Alkermes, Inc. $79.50 10/02/2025 Non-covered Recipient Entity
CULLMAN CLINICAL TRIALS, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208623418
Principal investigator 1 Alkermes, Inc. $56.40 10/02/2025 Non-covered Recipient Entity
CULLMAN CLINICAL TRIALS, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208624064
Principal investigator 1 Alkermes, Inc. $75.20 10/02/2025 Non-covered Recipient Entity
CULLMAN CLINICAL TRIALS, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208624929
Principal investigator 1 Alkermes, Inc. $92.75 10/02/2025 Non-covered Recipient Entity
CULLMAN CLINICAL TRIALS, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208625642
Principal investigator 1 Alkermes, Inc. $75.20 10/02/2025 Non-covered Recipient Entity
CULLMAN CLINICAL TRIALS, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208626902
Principal investigator 1 Alkermes, Inc. $70.00 09/29/2025 Non-covered Recipient Entity
CULLMAN CLINICAL TRIALS, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208621076
Principal investigator 1 Alkermes, Inc. $1,196.53 09/08/2025 Non-covered Recipient Entity
CULLMAN CLINICAL TRIALS, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208618791
Principal investigator 1 Alkermes, Inc. $1,045.00 09/04/2025 Non-covered Recipient Entity
CULLMAN CLINICAL TRIALS, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208620183
Principal investigator 1 GENZYME CORPORATION $2,099.00 04/28/2025 Non-covered Recipient Entity
New Horizon Research Group Inc
A Randomized, Double-Blind, Placebo Controlled Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Patients With Uncontrolled Moderate to Severe Asthma No dispute reported 06/30/2026 1226110597
Principal investigator 1 ModernaTX, Inc. $28,129.61 04/02/2025 Non-covered Recipient Entity
CULLMAN RESEARCH CENTER LLC
Study of mRNA-1010 Seasonal Influenza Vaccine in Adults No dispute reported 06/30/2026 1252956745
Principal investigator 1 SANOFI US SERVICES INC. $500.00 04/02/2025 Non-covered Recipient Entity
New Horizon Research Group Inc
A Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Pivotal Study to Assess the Efficacy, Safety, and Tolerability of Dupilumab in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) With Type 2 Inflammation No dispute reported 06/30/2026 1226110560
Principal investigator 1 ModernaTX, Inc. $1,100.00 02/12/2025 Non-covered Recipient Entity
CULLMAN RESEARCH CENTER LLC
Study of mRNA-1010 Seasonal Influenza Vaccine in Adults No dispute reported 06/30/2026 1252956759
Principal investigator 1 ModernaTX, Inc. $4,080.00 02/05/2025 Non-covered Recipient Entity
CULLMAN RESEARCH CENTER LLC
Study of mRNA-1010 Seasonal Influenza Vaccine in Adults No dispute reported 06/30/2026 1252956747
Principal investigator 1 ModernaTX, Inc. $4,893.34 02/05/2025 Non-covered Recipient Entity
CULLMAN RESEARCH CENTER LLC
Study of mRNA-1010 Seasonal Influenza Vaccine in Adults No dispute reported 06/30/2026 1252956749
Principal investigator 1 ModernaTX, Inc. $2,000.00 02/05/2025 Non-covered Recipient Entity
CULLMAN RESEARCH CENTER LLC
Study of mRNA-1010 Seasonal Influenza Vaccine in Adults No dispute reported 06/30/2026 1252956751
Principal investigator 1 ModernaTX, Inc. $23,009.56 02/05/2025 Non-covered Recipient Entity
CULLMAN RESEARCH CENTER LLC
Study of mRNA-1010 Seasonal Influenza Vaccine in Adults No dispute reported 06/30/2026 1252956753
Principal investigator 1 ModernaTX, Inc. $4,425.00 02/05/2025 Non-covered Recipient Entity
CULLMAN RESEARCH CENTER LLC
Study of mRNA-1010 Seasonal Influenza Vaccine in Adults No dispute reported 06/30/2026 1252956755
Principal investigator 1 ModernaTX, Inc. $27,201.71 02/05/2025 Non-covered Recipient Entity
CULLMAN RESEARCH CENTER LLC
Study of mRNA-1010 Seasonal Influenza Vaccine in Adults No dispute reported 06/30/2026 1252956757